SNNLive interview with J.J. Finkelstein, President & CEO of RegeneRx Biopharmaceuticals, Inc. at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY.
Watch the video interview.
Shareholder letter - Tuesday February 17, 2015
Link to document.
RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
October 28, 2015
RegeneRx Analyst Report Update Issued by SeeThruEquity, LLC
October 23, 2015
RegeneRx Updates on Asian Ophthalmic Clinical Trials
October 21, 2015
RegeneRx Updates on U.S. Ophthalmic Clinical Trials
September 2, 2015
RegeneRx to Present at Rodman & Renshaw Global Investment Conference